4-PHENYL-2-(1H-1,2,3-TRIAZOL-4-YL)PIPERIDIN-4-OL DERIVATIVES AS INHIBITORS OF APOL1 AND METHODS OF USING SAME
The disclosure provides at least one compound, tautomer, deuterated derivative, or pharmaceutically acceptable salt chosen from compounds of Formula (I), tautomers thereof, deuterated derivatives of those compounds or tautomers, and pharmaceutically acceptable salts of any of the foregoing, composit...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | OLSEN, JESSICA H GARCIA BARRANTES, PEDRO M DOLGIKH, ELENA SENTER, TIMOTHY J DANIEL, KEVIN B STONE, STEVEN D TSAY, CHARLENE DAKIN, LESLIE A BRODNEY, MICHAEL A SHIMIZU, AKIRA J MEDEK, ALES |
| description | The disclosure provides at least one compound, tautomer, deuterated derivative, or pharmaceutically acceptable salt chosen from compounds of Formula (I), tautomers thereof, deuterated derivatives of those compounds or tautomers, and pharmaceutically acceptable salts of any of the foregoing, compositions comprising the same, and methods of using the same, including uses in treating APOL1-mediated diseases, including pancreatic cancer, focal segmental glomerulosclerosis (FSGS), and/or non-diabetic kidney disease (NDKD).
L'invention concerne au moins un composé, un tautomère, un dérivé deutéré ou un sel pharmaceutiquement acceptable choisi parmi les composés de formule I, des tautomères de ceux-ci, des dérivés deutérés de ces composés ou tautomères, et des sels pharmaceutiquement acceptables de l'un quelconque de ceux-ci, des compositions les comprenant, et des procédés d'utilisation associés, comprenant des utilisations dans le traitement de maladies médiées par APOL1, comprenant le cancer du pancréas, la hyalinose segmentaire et focale (HSF) et/ou la néphropathie non diabétique (NND). (Formule I) |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA3239394A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA3239394A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA3239394A13</originalsourceid><addsrcrecordid>eNqNirsKwjAUQLs4iPoPd1ToHdJ06Rib1FxIk9LEQl1KkTj5KNT_xyJ-gNPhHM46eeTYaGV7gxnumUaWZinH0JK4OIM59ubQUKNakmQXdQbkIp0I1CkPwgNZTUcKrvXgKhCNMwyElVCroJ38xrMnewIvarVNVrfxPsfdj5sEKhVKjXF6DXGexmt8xvdQCp7xghe5YPyP5QPQszT_</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>4-PHENYL-2-(1H-1,2,3-TRIAZOL-4-YL)PIPERIDIN-4-OL DERIVATIVES AS INHIBITORS OF APOL1 AND METHODS OF USING SAME</title><source>esp@cenet</source><creator>OLSEN, JESSICA H ; GARCIA BARRANTES, PEDRO M ; DOLGIKH, ELENA ; SENTER, TIMOTHY J ; DANIEL, KEVIN B ; STONE, STEVEN D ; TSAY, CHARLENE ; DAKIN, LESLIE A ; BRODNEY, MICHAEL A ; SHIMIZU, AKIRA J ; MEDEK, ALES</creator><creatorcontrib>OLSEN, JESSICA H ; GARCIA BARRANTES, PEDRO M ; DOLGIKH, ELENA ; SENTER, TIMOTHY J ; DANIEL, KEVIN B ; STONE, STEVEN D ; TSAY, CHARLENE ; DAKIN, LESLIE A ; BRODNEY, MICHAEL A ; SHIMIZU, AKIRA J ; MEDEK, ALES</creatorcontrib><description>The disclosure provides at least one compound, tautomer, deuterated derivative, or pharmaceutically acceptable salt chosen from compounds of Formula (I), tautomers thereof, deuterated derivatives of those compounds or tautomers, and pharmaceutically acceptable salts of any of the foregoing, compositions comprising the same, and methods of using the same, including uses in treating APOL1-mediated diseases, including pancreatic cancer, focal segmental glomerulosclerosis (FSGS), and/or non-diabetic kidney disease (NDKD).
L'invention concerne au moins un composé, un tautomère, un dérivé deutéré ou un sel pharmaceutiquement acceptable choisi parmi les composés de formule I, des tautomères de ceux-ci, des dérivés deutérés de ces composés ou tautomères, et des sels pharmaceutiquement acceptables de l'un quelconque de ceux-ci, des compositions les comprenant, et des procédés d'utilisation associés, comprenant des utilisations dans le traitement de maladies médiées par APOL1, comprenant le cancer du pancréas, la hyalinose segmentaire et focale (HSF) et/ou la néphropathie non diabétique (NND). (Formule I)</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230608&DB=EPODOC&CC=CA&NR=3239394A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,782,887,25571,76555</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230608&DB=EPODOC&CC=CA&NR=3239394A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>OLSEN, JESSICA H</creatorcontrib><creatorcontrib>GARCIA BARRANTES, PEDRO M</creatorcontrib><creatorcontrib>DOLGIKH, ELENA</creatorcontrib><creatorcontrib>SENTER, TIMOTHY J</creatorcontrib><creatorcontrib>DANIEL, KEVIN B</creatorcontrib><creatorcontrib>STONE, STEVEN D</creatorcontrib><creatorcontrib>TSAY, CHARLENE</creatorcontrib><creatorcontrib>DAKIN, LESLIE A</creatorcontrib><creatorcontrib>BRODNEY, MICHAEL A</creatorcontrib><creatorcontrib>SHIMIZU, AKIRA J</creatorcontrib><creatorcontrib>MEDEK, ALES</creatorcontrib><title>4-PHENYL-2-(1H-1,2,3-TRIAZOL-4-YL)PIPERIDIN-4-OL DERIVATIVES AS INHIBITORS OF APOL1 AND METHODS OF USING SAME</title><description>The disclosure provides at least one compound, tautomer, deuterated derivative, or pharmaceutically acceptable salt chosen from compounds of Formula (I), tautomers thereof, deuterated derivatives of those compounds or tautomers, and pharmaceutically acceptable salts of any of the foregoing, compositions comprising the same, and methods of using the same, including uses in treating APOL1-mediated diseases, including pancreatic cancer, focal segmental glomerulosclerosis (FSGS), and/or non-diabetic kidney disease (NDKD).
L'invention concerne au moins un composé, un tautomère, un dérivé deutéré ou un sel pharmaceutiquement acceptable choisi parmi les composés de formule I, des tautomères de ceux-ci, des dérivés deutérés de ces composés ou tautomères, et des sels pharmaceutiquement acceptables de l'un quelconque de ceux-ci, des compositions les comprenant, et des procédés d'utilisation associés, comprenant des utilisations dans le traitement de maladies médiées par APOL1, comprenant le cancer du pancréas, la hyalinose segmentaire et focale (HSF) et/ou la néphropathie non diabétique (NND). (Formule I)</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNirsKwjAUQLs4iPoPd1ToHdJ06Rib1FxIk9LEQl1KkTj5KNT_xyJ-gNPhHM46eeTYaGV7gxnumUaWZinH0JK4OIM59ubQUKNakmQXdQbkIp0I1CkPwgNZTUcKrvXgKhCNMwyElVCroJ38xrMnewIvarVNVrfxPsfdj5sEKhVKjXF6DXGexmt8xvdQCp7xghe5YPyP5QPQszT_</recordid><startdate>20230608</startdate><enddate>20230608</enddate><creator>OLSEN, JESSICA H</creator><creator>GARCIA BARRANTES, PEDRO M</creator><creator>DOLGIKH, ELENA</creator><creator>SENTER, TIMOTHY J</creator><creator>DANIEL, KEVIN B</creator><creator>STONE, STEVEN D</creator><creator>TSAY, CHARLENE</creator><creator>DAKIN, LESLIE A</creator><creator>BRODNEY, MICHAEL A</creator><creator>SHIMIZU, AKIRA J</creator><creator>MEDEK, ALES</creator><scope>EVB</scope></search><sort><creationdate>20230608</creationdate><title>4-PHENYL-2-(1H-1,2,3-TRIAZOL-4-YL)PIPERIDIN-4-OL DERIVATIVES AS INHIBITORS OF APOL1 AND METHODS OF USING SAME</title><author>OLSEN, JESSICA H ; GARCIA BARRANTES, PEDRO M ; DOLGIKH, ELENA ; SENTER, TIMOTHY J ; DANIEL, KEVIN B ; STONE, STEVEN D ; TSAY, CHARLENE ; DAKIN, LESLIE A ; BRODNEY, MICHAEL A ; SHIMIZU, AKIRA J ; MEDEK, ALES</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA3239394A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>OLSEN, JESSICA H</creatorcontrib><creatorcontrib>GARCIA BARRANTES, PEDRO M</creatorcontrib><creatorcontrib>DOLGIKH, ELENA</creatorcontrib><creatorcontrib>SENTER, TIMOTHY J</creatorcontrib><creatorcontrib>DANIEL, KEVIN B</creatorcontrib><creatorcontrib>STONE, STEVEN D</creatorcontrib><creatorcontrib>TSAY, CHARLENE</creatorcontrib><creatorcontrib>DAKIN, LESLIE A</creatorcontrib><creatorcontrib>BRODNEY, MICHAEL A</creatorcontrib><creatorcontrib>SHIMIZU, AKIRA J</creatorcontrib><creatorcontrib>MEDEK, ALES</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>OLSEN, JESSICA H</au><au>GARCIA BARRANTES, PEDRO M</au><au>DOLGIKH, ELENA</au><au>SENTER, TIMOTHY J</au><au>DANIEL, KEVIN B</au><au>STONE, STEVEN D</au><au>TSAY, CHARLENE</au><au>DAKIN, LESLIE A</au><au>BRODNEY, MICHAEL A</au><au>SHIMIZU, AKIRA J</au><au>MEDEK, ALES</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>4-PHENYL-2-(1H-1,2,3-TRIAZOL-4-YL)PIPERIDIN-4-OL DERIVATIVES AS INHIBITORS OF APOL1 AND METHODS OF USING SAME</title><date>2023-06-08</date><risdate>2023</risdate><abstract>The disclosure provides at least one compound, tautomer, deuterated derivative, or pharmaceutically acceptable salt chosen from compounds of Formula (I), tautomers thereof, deuterated derivatives of those compounds or tautomers, and pharmaceutically acceptable salts of any of the foregoing, compositions comprising the same, and methods of using the same, including uses in treating APOL1-mediated diseases, including pancreatic cancer, focal segmental glomerulosclerosis (FSGS), and/or non-diabetic kidney disease (NDKD).
L'invention concerne au moins un composé, un tautomère, un dérivé deutéré ou un sel pharmaceutiquement acceptable choisi parmi les composés de formule I, des tautomères de ceux-ci, des dérivés deutérés de ces composés ou tautomères, et des sels pharmaceutiquement acceptables de l'un quelconque de ceux-ci, des compositions les comprenant, et des procédés d'utilisation associés, comprenant des utilisations dans le traitement de maladies médiées par APOL1, comprenant le cancer du pancréas, la hyalinose segmentaire et focale (HSF) et/ou la néphropathie non diabétique (NND). (Formule I)</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA3239394A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | 4-PHENYL-2-(1H-1,2,3-TRIAZOL-4-YL)PIPERIDIN-4-OL DERIVATIVES AS INHIBITORS OF APOL1 AND METHODS OF USING SAME |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T12%3A52%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=OLSEN,%20JESSICA%20H&rft.date=2023-06-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA3239394A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |